BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29174470)

  • 21. Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: A 20-year experience.
    Tan WP; Kotamarti S; Chen E; Mahle R; Arcot R; Chang A; Ayala A; Michael Z; Seguier D; Polascik TJ
    Cancer; 2022 Nov; 128(21):3824-3830. PubMed ID: 36107496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition of biochemical success following primary whole gland prostate cryoablation.
    Levy DA; Ross AE; ElShafei A; Krishnan N; Hatem A; Jones JS
    J Urol; 2014 Nov; 192(5):1380-4. PubMed ID: 24813344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
    Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
    Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease.
    Baskin A; Charondo LB; Balakrishnan A; Cowan JE; Cooperberg MR; Carroll PR; Nguyen H; Shinohara K
    Urol Oncol; 2022 Oct; 40(10):451.e15-451.e20. PubMed ID: 35851186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
    De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
    BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal cryoablation for unilateral low-intermediate-risk prostate cancer: 63-month mean follow-up results of 41 patients.
    Lian H; Zhuang J; Yang R; Qu F; Wang W; Lin T; Guo H
    Int Urol Nephrol; 2016 Jan; 48(1):85-90. PubMed ID: 26531063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre.
    Wenske S; Quarrier S; Katz AE
    Eur Urol; 2013 Jul; 64(1):1-7. PubMed ID: 22840351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
    Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
    BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?
    ElShafei A; DeWitt-Foy M; Calaway A; Fernstrum AJ; Hijaz A; Muncey W; Alfahmy A; Mahran A; Mishra K; Stephen Jones J; Polascik TJ
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):507-513. PubMed ID: 33483626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
    Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
    Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of disease burden on cryoablation prostate-specific antigen outcomes.
    Levy DA; Li J; Jones S
    Urology; 2010 Feb; 75(2):478-81. PubMed ID: 19963251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
    Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
    Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage Cryoablation for Radiorecurrent Prostate Cancer: Initial Experience at a Regional Health Care System.
    Safavy S; Jabaji RB; Lu SM; Slezak JM; Cosmatos HA; Williams SG; Finley DS
    Perm J; 2019; 23():. PubMed ID: 31050644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of biochemical recurrence after primary focal cryosurgery (hemiablation) for localized prostate cancer: A multi-institutional analytic comparison of Phoenix and Stuttgart criteria.
    Kongnyuy M; Lipsky MJ; Islam S; Robins DJ; Hager S; Halpern DM; Kosinski KE; Schiff JT; Corcoran AT; Wenske S; Katz AE
    Urol Oncol; 2017 Aug; 35(8):530.e15-530.e19. PubMed ID: 28410986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cryosurgery of the prostate for nonsurgical candidates.
    Al Ekish S; Nayeemuddin M; Maddox M; Pareek G
    JSLS; 2013; 17(3):423-8. PubMed ID: 24018080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryosurgical ablation of the prostate: high risk patient outcomes.
    Prepelica KL; Okeke Z; Murphy A; Katz AE
    Cancer; 2005 Apr; 103(8):1625-30. PubMed ID: 15747374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal prostate cryoablation: initial results show cancer control and potency preservation.
    Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
    J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopsy Assessment of Oncologic Control 3 Years Following Primary Partial Gland Cryoablation: A Prospective Cohort Study of Men With Intermediate-risk Prostate Cancer.
    Wysock JS; Rapoport E; Hernandez H; Gogaj R; Lepor H
    J Urol; 2023 Sep; 210(3):454-464. PubMed ID: 37285232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended followup oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2c-T3b).
    Chin JL; Al-Zahrani AA; Autran-Gomez AM; Williams AK; Bauman G
    J Urol; 2012 Oct; 188(4):1170-5. PubMed ID: 22901586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of localized prostate cancer in elderly patients: the role of partial cryoablation.
    Selvaggio O; Finati M; Falagario UG; Silecchia G; Recchia M; Checchia AA; Milillo P; Sanguedolce F; Cindolo L; Busetto GM; Bettocchi C; Cormio L; Carrieri G
    Int Urol Nephrol; 2023 May; 55(5):1125-1132. PubMed ID: 36809642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.